Aurora Spine saw $4.4 million dollars in first-quarter sales, a less than 1% increase year over year, according to financial results posted May 28.
Seven more notes:
1. Revenues for the first quarter grew 0.4% year over year due to increased activity in the pain market and increased sales of lumbar and biologics products.
2. Sales to spine surgeons decreased related to fewer cervical implant sales.
3. Aurora Spine is re-releasing its Apollo plate and expects that more plates will be used with the DEXA-C implants in the near future.
4. Aurora Spine saw a gross profit margin of 62.6% compared to 58% in the first quarter of 2025.
5. Operating expenses were $2.98 million, up from $2.88 million in the same time last year. The slight increase was due to increase in total compensation, consulting fees, professional fees offset by decreases in research and development, marketing fees, and insurance premiums.
6. Aurora Spine saw a net loss of $202,854, down from a $349,678 net loss in the same period last year.
7. “During the quarter, our Zip, lumbar implants and newly created biologics division, were lead drivers of sales during the first quarter, demonstrating strength within the pain market, where we have been directly targeting sales efforts,” CEO Trent Northcutt said in the release. “We have additional work to conduct on the spine side of the business. Now that our Apollo cervical plates have been re-released to the market, we are focused on meeting with more spine surgeons and introducing them to the DEXA branded products, including the DEXA-C for cervical applications and the DEXA-L for lumbar (expanded availability expected in Q3 2026). These product offerings carry key differentiators and are sought out by the industry, especially in surgeries where bone density isn’t as strong. We expect sales of DEXA to build throughout the year. Our SiLO franchises were inline versus a year ago and we are focused on product extensions that we believe will offer more of a variety of SI Joint product for pain interventionalists.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
